INK-128 Catalog No.:M10703-10 and further antiallergic and anti-inflammatory

and further antiallergic and anti-inflammatory effects unrelated to H1-receptor binding

selective and cell-permeable p38 MAP kinase inhibitor with IC50 of 89 nM

BRD-7552 increases PDX1 mRNA levels by 2- to 4-fold

C1=NNC2=CC=CC=C21

DGAT1-IN-3 (50 mg/kg

INK-128 Catalog No.:M10703-10 and further antiallergic and anti-inflammatorySapanisertib, also known as TAK 228, MLN0128 and INK128, is a TORC1 2 inhibitor, is also an orally bioavailable inhibitor of raptor mTOR (TOR complex 1 or TORC1) and rictor mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. TORC1 2 inhibitor INK128 binds to and inhibits both TORC1 and TORC2 complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some